Cargando cotizaciones...
Previsión
El precio objetivo medio de los analistas es de 39,89 € (+30,79 %). La mediana es de 38,84 € (+27,34 %).
| Comprar |
15 |
| Mantener |
2 |
| Vender |
0 |
Noticias Ir al feed de noticias
Medline shares plunge in premarket trading after disappointing Q2 results
Medline shares lost 11.4% in premarket trading after the release of disappointing second-quarter 2026 results, intensifying concerns over profitability and cost pressure. The weak Q1 figures—showing declining net income and a compressed margin—set the backdrop, with further pressure from a UBS price-target cut and the resignation of the COO. The stock fell to $37.25, well below the analyst consensus of about $50.92 and closer to its 52-week low than its high. » Más en de.investing.com
Medline to become primary supplier for Allina Health
Medline has signed a primary supplier agreement with Allina Health that gives Allina access to medical‑surgical products and distribution services for its 12 hospitals and more than 90 clinics in Minnesota and western Wisconsin. The agreement is intended to strengthen supply security and to drive standardization of products, processes and data across the health system. Medline thereby expands an existing partnership and will provide supply‑chain solutions for Allina Health’s network. » Más en de.investing.com
Medline rents 1.6 million square feet of warehouse space in Northern California after fire
Medline has leased two distribution centers in Northern California totaling more than 1.6 million square feet: a 925,000‑square‑foot facility in Tracy for immediate use and a 709,000‑square‑foot site in Stockton scheduled to begin operations in January 2027. Capacity in the region rises about 45% within a month and replaces a previously fire‑destroyed 1‑million‑square‑foot center in Tracy. The new Tracy facility is less than 10 miles from the former site and is expected to take its first shipments in the coming months; in California Medline plans to expand distribution space to nearly 5 million square feet by mid‑2027. » Más en de.investing.com
Datos financieros de la empresa
| (EUR) | jun 2026 | |
|---|---|---|
| Ingresos | 6733,67 M | 15,26 % |
| Beneficio bruto | 1940,81 M | 32,30 % |
| Beneficio neto | 52,57 M | 81,39 % |
| EBITDA | 577,42 M | 19,17 % |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 25,29 mil M € |
Número de acciones | 845,61 M |
Máximo/mínimo de 52 semanas | 43,91 € - 28,04 € |
| Dividendos | No |
Beta | -0,41 |
Ratio P/E | 40,29 |
Ratio PEG | -1,34 |
Ratio P/B | 2,57 |
Ratio P/S | 0,98 |
Perfil de la empresa
| Nombre | MEDLINE INC. CL. A O.N. |
| CEO | James Boyle |
| Empleados | 45.000 |
Deep Dive
Descubrir activos
Los accionistas de MEDLINE INC. CL. A O.N. también invierten en los siguientes activos
